Biotech ETF
$8.62
last price
+4.50%
session
$69B
market cap
61
highest conviction
Where it earns weight.
Conviction answers one question: if the claim turns out to be true, how directly does this name benefit? The score sets the size, and the formula is published.
Healthspan
61/100Spread across small-cap biotech, where single-name risk is brutal.
Medicine shifts from treating disease late to extending the years a person stays healthy.
Build this bookPrototype figures. The price, session move, market cap and chart above are generated deterministically from the ticker text. They are not live quotes. The conviction scores and written reasons are real editorial judgements, described on the methodology page.